Therapy of microcirculatory disorders in severe acute pancreatitis: What mediators should we block?

Intensive Care Medicine

Volumn 28, Issue 2, 2002, Pages 139-146

  Eibl, Guido ^b   Buhr, Heinz J ^a   Foitzik, Thomas ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute pancreatitis; Endothelin; Experimental; Microcirculation; Vasoactive mediators

Indexed keywords

BEPAFANT; DARUSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; IA 29; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; SODIUM CHLORIDE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY FLOW; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; COLON; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; LAPAROTOMY; MALE; MICROCIRCULATION; NONHUMAN; PANCREAS; RAT;

ACUTE DISEASE; ANIMALS; ANTIBODIES; BILE ACIDS AND SALTS; CAERULEIN; CAPILLARY LEAK SYNDROME; INTERCELLULAR ADHESION MOLECULE-1; MALE; MICROCIRCULATION; PANCREATITIS; PLATELET MEMBRANE GLYCOPROTEINS; PROSPECTIVE STUDIES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, ENDOTHELIN; RECEPTORS, G-PROTEIN-COUPLED; VASCULAR DISEASES;

EID: 0036217468     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-001-1194-1     Document Type: Article

References (32)

1. Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis
2. Ingredients of organ dysfunction or failure
3. Natural course of acute pancreatitis
4. Inflammatory mediators in acute pancreatitis
5. Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow and survival in severe experimental pancreatitis
6. A better model of acute pancreatitis for evaluating therapy
7. Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists
8. Measurement of blood flow in pancreatic exchange capillaries with FITC-labeled erythrocytes
9. Intestinal microcirculation and gut permeability in acute pancreatitis: Early changes and therapeutic implications
10. Cap image - A new kind of computer-assisted video image analysis system for dynamic capillary microscopy
11. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats
12. Experimental models of acute pancreatitis: Are they suitable for evaluating therapy?
13. Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis
14. Effect of recombinant platelet-activating factor acetylhydrolase on two models of experimental acute pancreatitis
15. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis
16. Randomized, double-blind phase II trial of lexipafant, a platelet-activating factor antagonist, in human acute pancreatitis
17. The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats
18. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury
19. Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1
20. Enhancement by endothelin-1 of microvascular permeability via the activation of ETA receptors
21. Is the pancreas especially susceptible to endothelin?
22. Therapy for microcirculatory disorders in severe acute pancreatitis: Comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist
23. Role of platelet-activating factor antagonism in haemorrhagic shock in pigs
24. Effects of endothelin and endothelin receptor antagonism in arteriolar and venular microcirculation
25. Possible induction of intercellular adhesion molecule-1 (ICAM-1) expression on endothelial cells by platelet-activating factor (PAF)
26. Oxidative stress during platelet-activating factor-induced microvascular dysfunction
27. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction
28. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: Role of ET(A) receptors and platelet-activating factor
29. Endothelin-1 induces neutrophil-independent vascular injury in the rat gastric microcirculation
30. Different effects of endothelin-1 on cAMP- and cGMP-mediated vascular relaxation in human arteries and veins: Comparison with norepinephrine
31. Contractile proteins of endothelial cells, platelets and smooth muscle